腫瘍分子診断のグローバル市場2023-2027:試薬・キット、機器

■ 英語タイトル:Global Oncology Molecular Diagnostics Market 2023-2027

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR75956-23)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR75956-23
■ 発行日:2023年7月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[腫瘍分子診断のグローバル市場2023-2027:試薬・キット、機器]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

腫瘍分子診断の世界市場 2023-2027
腫瘍分子診断市場は、2022-2027年に2億9,808万米ドルの成長が予測され、予測期間中のCAGRは11.82%で加速すると予測されています。当レポートでは、腫瘍分子診断市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。
当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、世界的な癌の有病率の増加、高齢者人口の増加、ゲノミクスとプロテオミクスにおけるマイクロアレイの採用増加によって牽引されています。

Technavioの腫瘍分子診断市場は以下のようにセグメント化されています:

製品別
- 試薬・キット
- 機器

タイプ別
- 乳がん
- 大腸がん
- 前立腺がん
- 肝臓がん、その他

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、腫瘍分子診断における次世代シーケンサーの統合が、今後数年間における腫瘍分子診断市場の成長を促進する主要な理由の1つであると特定しています。また、さまざまなコラボレーション戦略の採用や、がんの診断と治療における新興国への注目の高まりは、市場の大きな需要につながるでしょう。

本レポートでは、腫瘍分子診断市場について以下の領域をカバーしています:
- 腫瘍分子診断市場の規模
- 腫瘍分子診断市場予測
- 腫瘍分子診断市場の業界分析

強固なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートでは、Abbott Laboratories社、Agilent Technologies Inc.社、Becton Dickinson and Co.社、Biocartis NV社、bioMerieux SA社、Danaher Corp、 DiaSorin SpA、Exact Sciences Corp.、F. Hoffmann La Roche Ltd.、Grifols SA、Hologic Inc.、HTG Molecular Diagnostics Inc.、Illumina Inc.、MDXHEALTH SA、Myriad Genetics Inc.、QIAGEN NV、QuidelOrtho Corp.、Siemens Healthineers AG、Sysmex Corp.、TBG Diagnostics Ltd.、Thermo Fisher Scientific Inc.、Veracyte Inc.などを分析しています。また、腫瘍分子診断市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

当レポートは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 製品別市場分析
7 タイプ別市場分析
8 顧客状況
9 地域別状況
11 企業状況
12 企業分析
13 付録

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global oncology molecular diagnostics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global oncology molecular diagnostics market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 Type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Reagents and kits – Market size and forecast 2022-2027
o Exhibit 34: Chart on Reagents and kits – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Reagents and kits – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Reagents and kits – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Reagents and kits – Year-over-year growth 2022-2027 (%)
o 6.4 Instruments – Market size and forecast 2022-2027
o Exhibit 38: Chart on Instruments – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Instruments – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Instruments – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Instruments – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 44: Chart on Type – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Type – Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 46: Chart on Comparison by Type
o Exhibit 47: Data Table on Comparison by Type
o 7.3 Breast cancer – Market size and forecast 2022-2027
o Exhibit 48: Chart on Breast cancer – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Breast cancer – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Breast cancer – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Breast cancer – Year-over-year growth 2022-2027 (%)
o 7.4 Colorectal cancer – Market size and forecast 2022-2027
o Exhibit 52: Chart on Colorectal cancer – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Colorectal cancer – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Colorectal cancer – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Colorectal cancer – Year-over-year growth 2022-2027 (%)
o 7.5 Prostate cancer – Market size and forecast 2022-2027
o Exhibit 56: Chart on Prostate cancer – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Prostate cancer – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Prostate cancer – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Prostate cancer – Year-over-year growth 2022-2027 (%)
o 7.6 Liver cancer and others – Market size and forecast 2022-2027
o Exhibit 60: Chart on Liver cancer and others – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Liver cancer and others – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Liver cancer and others – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Liver cancer and others – Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Type
o Exhibit 64: Market opportunity by Type ($ million)
o Exhibit 65: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 71: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 87: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 91: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 Japan – Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.11 France – Market size and forecast 2022-2027
o Exhibit 103: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 115: Abbott Laboratories – Overview
o Exhibit 116: Abbott Laboratories – Business segments
o Exhibit 117: Abbott Laboratories – Key news
o Exhibit 118: Abbott Laboratories – Key offerings
o Exhibit 119: Abbott Laboratories – Segment focus
o 12.4 Agilent Technologies Inc.
o Exhibit 120: Agilent Technologies Inc. – Overview
o Exhibit 121: Agilent Technologies Inc. – Business segments
o Exhibit 122: Agilent Technologies Inc. – Key offerings
o Exhibit 123: Agilent Technologies Inc. – Segment focus
o 12.5 bioMerieux SA
o Exhibit 124: bioMerieux SA – Overview
o Exhibit 125: bioMerieux SA – Product / Service
o Exhibit 126: bioMerieux SA – Key offerings
o 12.6 Danaher Corp.
o Exhibit 127: Danaher Corp. – Overview
o Exhibit 128: Danaher Corp. – Business segments
o Exhibit 129: Danaher Corp. – Key news
o Exhibit 130: Danaher Corp. – Key offerings
o Exhibit 131: Danaher Corp. – Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 132: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 133: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 134: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 135: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 136: F. Hoffmann La Roche Ltd. – Segment focus
o 12.8 Hologic Inc.
o Exhibit 137: Hologic Inc. – Overview
o Exhibit 138: Hologic Inc. – Business segments
o Exhibit 139: Hologic Inc. – Key news
o Exhibit 140: Hologic Inc. – Key offerings
o Exhibit 141: Hologic Inc. – Segment focus
o 12.9 HTG Molecular Diagnostics Inc.
o Exhibit 142: HTG Molecular Diagnostics Inc. – Overview
o Exhibit 143: HTG Molecular Diagnostics Inc. – Product / Service
o Exhibit 144: HTG Molecular Diagnostics Inc. – Key offerings
o 12.10 Illumina Inc.
o Exhibit 145: Illumina Inc. – Overview
o Exhibit 146: Illumina Inc. – Business segments
o Exhibit 147: Illumina Inc. – Key news
o Exhibit 148: Illumina Inc. – Key offerings
o Exhibit 149: Illumina Inc. – Segment focus
o 12.11 Myriad Genetics Inc.
o Exhibit 150: Myriad Genetics Inc. – Overview
o Exhibit 151: Myriad Genetics Inc. – Product / Service
o Exhibit 152: Myriad Genetics Inc. – Key offerings
o 12.12 QIAGEN NV
o Exhibit 153: QIAGEN NV – Overview
o Exhibit 154: QIAGEN NV – Product / Service
o Exhibit 155: QIAGEN NV – Key news
o Exhibit 156: QIAGEN NV – Key offerings
o 12.13 Siemens Healthineers AG
o Exhibit 157: Siemens Healthineers AG – Overview
o Exhibit 158: Siemens Healthineers AG – Business segments
o Exhibit 159: Siemens Healthineers AG – Key news
o Exhibit 160: Siemens Healthineers AG – Key offerings
o Exhibit 161: Siemens Healthineers AG – Segment focus
o 12.14 Sysmex Corp.
o Exhibit 162: Sysmex Corp. – Overview
o Exhibit 163: Sysmex Corp. – Business segments
o Exhibit 164: Sysmex Corp. – Key offerings
o Exhibit 165: Sysmex Corp. – Segment focus
o 12.15 TBG Diagnostics Ltd.
o Exhibit 166: TBG Diagnostics Ltd. – Overview
o Exhibit 167: TBG Diagnostics Ltd. – Product / Service
o Exhibit 168: TBG Diagnostics Ltd. – Key offerings
o 12.16 Thermo Fisher Scientific Inc.
o Exhibit 169: Thermo Fisher Scientific Inc. – Overview
o Exhibit 170: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 171: Thermo Fisher Scientific Inc. – Key news
o Exhibit 172: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 173: Thermo Fisher Scientific Inc. – Segment focus
o 12.17 Veracyte Inc.
o Exhibit 174: Veracyte Inc. – Overview
o Exhibit 175: Veracyte Inc. – Product / Service
o Exhibit 176: Veracyte Inc. – Key offerings
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global oncology molecular diagnostics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Reagents and kits – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Reagents and kits – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Reagents and kits – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Reagents and kits – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Instruments – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Instruments – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Instruments – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Instruments – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Type – Market share 2022-2027 (%)
Exhibits45: Data Table on Type – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Breast cancer – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Breast cancer – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Breast cancer – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Breast cancer – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Colorectal cancer – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Colorectal cancer – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Colorectal cancer – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Colorectal cancer – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Prostate cancer – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Prostate cancer – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Prostate cancer – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Prostate cancer – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Liver cancer and others – Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Liver cancer and others – Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Liver cancer and others – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Liver cancer and others – Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Type ($ million)
Exhibits65: Data Table on Market opportunity by Type ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories – Overview
Exhibits116: Abbott Laboratories – Business segments
Exhibits117: Abbott Laboratories – Key news
Exhibits118: Abbott Laboratories – Key offerings
Exhibits119: Abbott Laboratories – Segment focus
Exhibits120: Agilent Technologies Inc. – Overview
Exhibits121: Agilent Technologies Inc. – Business segments
Exhibits122: Agilent Technologies Inc. – Key offerings
Exhibits123: Agilent Technologies Inc. – Segment focus
Exhibits124: bioMerieux SA – Overview
Exhibits125: bioMerieux SA – Product / Service
Exhibits126: bioMerieux SA – Key offerings
Exhibits127: Danaher Corp. – Overview
Exhibits128: Danaher Corp. – Business segments
Exhibits129: Danaher Corp. – Key news
Exhibits130: Danaher Corp. – Key offerings
Exhibits131: Danaher Corp. – Segment focus
Exhibits132: F. Hoffmann La Roche Ltd. – Overview
Exhibits133: F. Hoffmann La Roche Ltd. – Business segments
Exhibits134: F. Hoffmann La Roche Ltd. – Key news
Exhibits135: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits136: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits137: Hologic Inc. – Overview
Exhibits138: Hologic Inc. – Business segments
Exhibits139: Hologic Inc. – Key news
Exhibits140: Hologic Inc. – Key offerings
Exhibits141: Hologic Inc. – Segment focus
Exhibits142: HTG Molecular Diagnostics Inc. – Overview
Exhibits143: HTG Molecular Diagnostics Inc. – Product / Service
Exhibits144: HTG Molecular Diagnostics Inc. – Key offerings
Exhibits145: Illumina Inc. – Overview
Exhibits146: Illumina Inc. – Business segments
Exhibits147: Illumina Inc. – Key news
Exhibits148: Illumina Inc. – Key offerings
Exhibits149: Illumina Inc. – Segment focus
Exhibits150: Myriad Genetics Inc. – Overview
Exhibits151: Myriad Genetics Inc. – Product / Service
Exhibits152: Myriad Genetics Inc. – Key offerings
Exhibits153: QIAGEN NV – Overview
Exhibits154: QIAGEN NV – Product / Service
Exhibits155: QIAGEN NV – Key news
Exhibits156: QIAGEN NV – Key offerings
Exhibits157: Siemens Healthineers AG – Overview
Exhibits158: Siemens Healthineers AG – Business segments
Exhibits159: Siemens Healthineers AG – Key news
Exhibits160: Siemens Healthineers AG – Key offerings
Exhibits161: Siemens Healthineers AG – Segment focus
Exhibits162: Sysmex Corp. – Overview
Exhibits163: Sysmex Corp. – Business segments
Exhibits164: Sysmex Corp. – Key offerings
Exhibits165: Sysmex Corp. – Segment focus
Exhibits166: TBG Diagnostics Ltd. – Overview
Exhibits167: TBG Diagnostics Ltd. – Product / Service
Exhibits168: TBG Diagnostics Ltd. – Key offerings
Exhibits169: Thermo Fisher Scientific Inc. – Overview
Exhibits170: Thermo Fisher Scientific Inc. – Business segments
Exhibits171: Thermo Fisher Scientific Inc. – Key news
Exhibits172: Thermo Fisher Scientific Inc. – Key offerings
Exhibits173: Thermo Fisher Scientific Inc. – Segment focus
Exhibits174: Veracyte Inc. – Overview
Exhibits175: Veracyte Inc. – Product / Service
Exhibits176: Veracyte Inc. – Key offerings
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR75956-23 )"腫瘍分子診断のグローバル市場2023-2027:試薬・キット、機器" (英文:Global Oncology Molecular Diagnostics Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。